iomeprol has been researched along with Dyslipidemias in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tajiri, K | 1 |
| Maruyama, H | 1 |
| Sato, A | 1 |
| Shimojo, N | 1 |
| Saito, T | 1 |
| Endo, M | 1 |
| Aihara, H | 1 |
| Kawano, S | 1 |
| Watanabe, S | 1 |
| Sakai, S | 1 |
| Aonuma, K | 1 |
1 other study available for iomeprol and Dyslipidemias
| Article | Year |
|---|---|
Prediction of chronic renal insufficiency after coronary angiography by an early increase in oxidative stress and decrease in glomerular filtration rate.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; | 2011 |